Changes in carnitine palmitoyltransferase-i mrna abundance produced by hyperthyroidism and hypothyroidism parallel changes in activity

Keyphrases

• Hypothyroidism 100%
• Carnitine Palmitoyltransferase 1A (CPT1A) 100%
• Parallel Changes 100%
• Commercially Pure Titanium (CP-Ti) 100%
• Hyperthyroidism 100%
• Thyroid Hormones 66%
• Hypothyroid 66%
• Hyperthyroid 66%
• Liver 33%
• Complementary DNA (cDNA) 33%
• MRNA Level 33%
• Enzyme Activity 33%
• PCR Amplification 33%
• MRNA Abundance 33%
• Rat Liver 33%
• Reverse Transcription 33%
• Euthyroid 33%

Pharmacology, Toxicology and Pharmaceutical Science

• Thyroid Hormone 100%
• Hypothyroidism 100%
• Carnitine Palmitoyltransferase 100%
• Hyperthyroidism 100%
• Messenger RNA 100%
• Complementary DNA 50%
• Carnitine Palmitoyltransferase I 50%
• Liotrix 50%

Biochemistry, Genetics and Molecular Biology

• Carnitine O-Palmitoyltransferase 100%
• Messenger RNA 100%
• Thyroid Hormone 100%
• RNA 50%
• Enzyme Activity 50%
• Reverse Transcription 50%
• Carnitine Palmitoyltransferase I 50%